Ultrasound-Guided Platelet-Rich Plasma Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation
Starting soon · Not applicable
Conditions studied: Neuroma, Phantom Limb Pain After Amputation, Stump Pain, Platelet-rich Plasma (PRP)
In brief
Patients with combat-related amputations frequently experience chronic neuroma pain that may interfere with rehabilitation, prosthesis use, mobility, sleep, and quality of life. Current treatment approaches often provide only temporary pain relief. Platelet-rich plasma (PRP) has emerged as a potential regenerative treatment option because of its possible effects on tissue healing, neuroinflammation, and peripheral nerve irritation. However, its role in the treatment of chronic neuroma pain after amputation remains unclear. This prospective multicenter controlled study aims to compare ultrasound-guided PRP injection around the neuroma with ultrasound-guided local anesthetic injection in patients with chronic neuroma pain after combat-related amputation. Participants will undergo one of the two injection treatments and will be followed over time to evaluate changes in pain intensity, neuropathic pain symptoms, phantom limb pain, prosthesis tolerance, and functional outcomes. The goal of the study is to evaluate the safety, feasibility, and potential clinical effectiveness of PRP injection for chronic neuroma pain following combat-related amputation.
Key facts
- Study ID
- NCT07624890
- Run by
- Ukrainian Society of Regional Anesthesia and Pain Therapy
- People needed
- 100
- Starts
- 2026-12-15
- Expected to finish
- 2026-12-15
- Last updated by the study team
- 2026-06-03
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- Combat-related limb amputation
- Chronic neuroma pain lasting ≥3 months
- Ultrasound-confirmed painful neuroma
- Average neuroma pain intensity ≥4/10 on the Numeric Rating Scale
- Persistent pain interfering with rehabilitation, prosthesis use, or daily activities
- Ability to undergo ultrasound-guided injection
- Stable analgesic regimen for at least 14 days before enrollment
- Ability to provide written informed consent
You may not qualify if…
- Active infection at or near the injection site
- Open wound preventing safe injection
- Previous PRP injection for neuroma pain within 6 months
- Previous neuroma surgery within 3 months
- Severe coagulopathy or platelet disorder
- Anticoagulant therapy contraindicating injection
- Active malignancy
- Severe uncontrolled systemic disease
- Known allergy to local anesthetics
- Inability to complete follow-up assessments
Where it is running
- Feofaniya Clinical Hospital — Kyiv, Ukraine
- Vinnitsya university hospital — Vinnytsia, Ukraine
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.